Jason Myers, PhD, CEO of the New Zealand AIDS Foundation, delves into how services related to HIV and AIDS in New Zealand—treatment and prevention, and now holistic services—have been spurred to expansion in recent years.
In the HIV/AIDS space, it is important to address not only sexual health but also physical and mental health—to take a more holistic approach to the overall well-being of the communities served, explained Jason Myers, PhD, CEO of the New Zealand AIDS Foundation (NZAF).
Transcript
How are HIV- and AIDS-related services covered in New Zealand?
We are very fortunate to have a very sophisticated public health system. So, all HIV treatments are fully funded, pre-exposure prophylaxis [PrEP] is fully funded, postexposure prophylaxis is fully funded. No insurance required. So that certainly is a barrier removed that we know exists in other jurisdictions.
In New Zealand, PrEP was funded from 1 March 2019 for those at highest risk of HIV. So for a gay man, for example, who presents and meets the criteria, they can access PrEP fully funded on the New Zealand government. The only cost involved would be $5 to fill the script at the pharmacy for a 3-month supply.
How has signing a new trust deed helped NZAF expand its services?
Essentially, our trust deed is our founding document, and that can be updated over time by our Trust Board, who is essentially our governing body. And essentially what the document does is set out the legal roles and parameters within which the organization can operate. In recent years, as I've just alluded to, the HIV landscape has changed significantly. And so the organization has had to ask questions about whether the deed was fit for purpose and what it might look like for us to meet current challenges and indeed position ourselves for the future of HIV. There were a couple of significant changes made in terms of the purposes of the deed, essentially the “what we can actually do” in terms of delivering programs and services.
First was the integration of both testing and services around STI [sexually transmitted infection] testing and prevention. And so here we're recognizing that particularly in the era of treatment-based HIV prevention, we have a new set of challenges to meet around, and so the board wanted to send a really clear signal this is a space that we want to work on. The other is to expand our ability to work beyond just sexual health into thinking also about the physical and mental health of the communities that we serve. So this is really just about taking a more holistic approach and holistic understanding toward the many things that can contribute to someone's overall well-being and that sexual health is just one of those. As an organization, we wanted to commit to expanding our remit into those different areas as resources that are moving forward.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
2 Commerce Drive
Cranbury, NJ 08512